Cargando…
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902188/ https://www.ncbi.nlm.nih.gov/pubmed/27284977 http://dx.doi.org/10.1371/journal.pmed.1002066 |
Ejemplares similares
-
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016) -
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016) -
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted
por: Nguyen, Thi Huyen Tram, et al.
Publicado: (2017) -
Correction: Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial
Publicado: (2017) -
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial
por: Konde, Mandy Kader, et al.
Publicado: (2017)